Skip to main content

Table 1 Patient characteristics in PSA progression tissue microarray

From: CD38 is methylated in prostate cancer and regulates extracellular NAD+

Characteristic No recurrence (n = 499) Recurrence (n = 499) p value
Age at surgery 59.0 (6.0) 58.8 (6.3) Matched
Race    Matched
 AA 39 (7.8%) 47 (9.4%)  
 White 440 (88.2%) 426 (85.4%)  
 Other 11 (2.2%) 19 (3.8%)  
Gleason sum    Matched
 5 3 (0.6%) 3 (0.6%)  
 6 69 (13.8%) 68 (13.6%)  
 7 314 (62.9%) 305 (61.1%)  
 8 113 (22.6%) 123 (24.6%)  
S stage    Matched
 1 67 (13.4%) 66 (13.2%)  
 2 260 (52.1%) 260 (52.1%)  
 3 172 (34.5%) 173 (34.7%)  
Pre-op PSA 11.0 (8.3) 12.3 (10.2) 0.026
Surgical margins + 110 (22.0%) 176 (35.3%) < 0.001
  1. The PSA progression tissue microarray contains tissue cores from 499 men who developed biochemical recurrence and 499 controls who did not develop recurrence, matched based on age, race, Gleason sum, and pathologic stage. Patient characteristics were summarized using means/standard deviation and frequencies/percentages